Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN105669554A details a novel method for Ivabradine hydrochloride impurity synthesis ensuring high purity and supply chain stability for global pharmaceutical manufacturing.
Patent CN109369678A reveals a cost-effective route for 6-epi-Porantheridine. Enhances supply chain reliability and reduces manufacturing complexity for global buyers.
Patent CN1049435C details novel artemisinin derivatives with phenyl radicals. Discover cost-effective synthesis routes and supply chain advantages for API manufacturing.
Novel synthetic route for Cefmetazole Sodium offering high purity and yield. Optimized for cost-effective cephalosporin manufacturing and scalable supply chain solutions.
Patent CN117417285B reveals metal-free route for Evocalcet intermediates offering cost reduction and supply chain reliability for pharmaceutical manufacturing partners globally
Discover the optimized glycine ester route for Rebamipide production in patent CN108069901B. Achieve cost reduction in pharmaceutical intermediates manufacturing with high yields.
Novel carbonylation route for phthalimide intermediates. Reduces steps, improves yield, ensures supply chain stability for pharma manufacturing.
Patent CN1653063A details a safer gastrointestinal prokinetic intermediate. Discover cost-effective synthesis routes and supply chain advantages for high-purity production.
Novel catalytic method for Thiotriazinone improves yield and reduces costs for Ceftriaxone Sodium manufacturing. Ideal for reliable pharmaceutical intermediate supplier partnerships.
Novel patent CN119060034A offers high-yield morpholine synthesis without chiral resolution ensuring cost-effective and reliable supply chain solutions for global pharmaceutical manufacturers.
Patent CN110240569A reveals a safer synthesis route for Tazobactam Sodium intermediates. Achieve high purity and reduced waste with scalable chemical processes.
Patent CN107099516B reveals a stable 7β-hydroxysteroid dehydrogenase mutant enabling high-concentration ursodeoxycholic acid synthesis with superior thermal stability and simplified downstream processing.
Patent CN111606962B reveals a safe, high-yield synthesis of levonorgestrel avoiding lithium ammonia. Ideal for reliable hormonal intermediate suppliers seeking cost reduction.
Novel 3-step synthesis of FR20 inhibitor avoids toxic reagents. High atom economy and scalable process for pharmaceutical intermediates.
Patent CN113387877A details a novel sulfamic acid sulfonation route for sodium picosulfate, offering superior purity and reduced inorganic residues for pharmaceutical manufacturing.
Patent CN112851719A details a streamlined 4-step synthesis of Jaspamycin, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN118755682A reveals BsSDR10 mutants for tetrabenazine reduction. Discover cost-effective, high-selectivity biocatalytic solutions for chiral drug manufacturing.
Patent CN102180886B details a novel enantioselective route to Galanthamine using organocatalysis, offering high purity and scalable manufacturing for pharmaceutical supply chains.
Patent CN1144779C details a high-yield 6-step route for FTY-720 precursors, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel Raney Nickel hydrogenation method ensures high purity 3-methyl-4-aminobenzoic acid. Reduces cost and waste for scalable pharmaceutical intermediate manufacturing supply chains.